Study #2023-0945
Establishing a tumor registry of patients with Mesonephric-like Adenocarcinoma (MLA)
MD Anderson Study Status
Enrolling
Treatment Agent
Description
To develop a database of medical information about patients with MLA in an effort to increase our understanding of the characteristics of MLA, which is the rarest form of endometrial carcinoma.
Resources and Links
Phone Number: 1-877-MDA-6789
Information and next steps
Disease:
Mesonephric-like Adenocarcinoma
Study phase:
Physician name:
Jeffrey How
Department:
Gynecologic Oncology & Reproductive Medicine
For general questions about clinical trials:
1-877-632-6789
Help #EndCancer
Give Now
Your gift will help make a tremendous difference.
Donate Blood
Our patients depend on blood and platelet donations.
Shop MD Anderson
Show your support for our mission through branded merchandise.